Rocket


News + Filings
Transactions



Ward Keith Wayne

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
12/14/2021Skye Bioscience, Inc.NMUSGrantDirector Option Grant (Right to Buy)250k$0.06$14.5k 12/14/2021
02/26/2019REATA PHARMACEUTICALS INCRETAConversionClass A common stock25.2k$0.00$0 02/25/2019
02/26/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock16.8k$91.00$1.5M 02/25/2019
02/26/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock8.4k$91.62$766.6k 02/25/2019
02/26/2019REATA PHARMACEUTICALS INCRETAExerciseClass B common stock16.8k$11.00$185k 02/25/2019
02/26/2019REATA PHARMACEUTICALS INCRETAExerciseClass B common stock8.4k$11.62$97.2k 02/25/2019
02/26/2019REATA PHARMACEUTICALS INCRETAConversionClass B common stock25.2k$0.00$0 02/25/2019
02/25/2019REATA PHARMACEUTICALS INCRETAExerciseClass B common stock15.2k$11.00$167k 02/25/2019
02/25/2019REATA PHARMACEUTICALS INCRETAConversionClass B common stock15.2k$0.00$0 02/25/2019
02/25/2019REATA PHARMACEUTICALS INCRETAConversionClass A common stock15.2k$0.00$0 02/25/2019
02/25/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock15.2k$91.00$1.4M 02/25/2019
01/31/2019REATA PHARMACEUTICALS INCRETAConversionClass A common stock4.2k$0.00$0 01/31/2019
01/31/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock1.4k$76.17$106.6k 01/31/2019
01/31/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock2.8k$76.97$211.7k 01/31/2019
01/31/2019REATA PHARMACEUTICALS INCRETAExerciseClass B common stock4.2k$11.62$48.2k 01/31/2019
01/31/2019REATA PHARMACEUTICALS INCRETAConversionClass B common stock4.2k$0.00$0 01/31/2019
01/14/2019REATA PHARMACEUTICALS INCRETAConversionClass A common stock8.6k$0.00$0 01/14/2019
01/14/2019REATA PHARMACEUTICALS INCRETAExerciseClass B common stock8.6k$11.62$100.2k 01/14/2019
01/14/2019REATA PHARMACEUTICALS INCRETAConversionClass B common stock8.6k$0.00$0 01/14/2019
01/02/2019REATA PHARMACEUTICALS INCRETAConversionClass A common stock4.2k$0.00$0 01/02/2019
01/02/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock2.8k$53.71$152k 01/02/2019
01/02/2019REATA PHARMACEUTICALS INCRETASaleClass A common stock1.3k$54.58$72k 01/02/2019
01/02/2019REATA PHARMACEUTICALS INCRETAExerciseClass B common stock4.2k$11.62$48.2k 01/02/2019
01/02/2019REATA PHARMACEUTICALS INCRETAConversionClass B common stock4.2k$0.00$0 01/02/2019
01/02/2019REATA PHARMACEUTICALS INCRETAGrantEmployee Stock Option (right to buy)34.5k$55.73$1.9M 01/02/2019
11/07/2018REATA PHARMACEUTICALS INCRETAConversionClass A common stock4.8k$0.00$0 11/07/2018
11/07/2018REATA PHARMACEUTICALS INCRETASaleClass A common stock3.7k$66.64$246.4k 11/07/2018
11/07/2018REATA PHARMACEUTICALS INCRETASaleClass A common stock1.1k$68.13$71.7k 11/07/2018
11/07/2018REATA PHARMACEUTICALS INCRETAExerciseClass B common stock4.8k$11.62$55.2k 11/07/2018
11/07/2018REATA PHARMACEUTICALS INCRETAConversionClass B common stock4.8k$0.00$0 11/07/2018
11/01/2018REATA PHARMACEUTICALS INCRETAConversionClass A common stock4.8k$0.00$0 11/01/2018
11/01/2018REATA PHARMACEUTICALS INCRETASaleClass A common stock4.8k$59.48$282.5k 11/01/2018
11/01/2018REATA PHARMACEUTICALS INCRETAExerciseClass B common stock4.8k$11.62$55.2k 11/01/2018
11/01/2018REATA PHARMACEUTICALS INCRETAConversionClass B common stock4.8k$0.00$0 11/01/2018
10/23/2018REATA PHARMACEUTICALS INCRETAConversionClass A common stock14.2k$0.00$0 10/23/2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy